CompletedNCT06057012
Safety study of Safety, Tolerability, Pharmacokinetics, and Descriptive Efficacy of BRII-296 in depression
This study evaluated the safety and effectiveness of BRII-296 for people with depression.
Medication studyAges 18–45United States
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of BRII-296 for people with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.
- Listed locations
- Sherman Oaks and 10 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: September 29, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 11
- Sponsor
- Brii Biosciences Limited
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT06057012
- Official title
Show the full official title
A Phase 2a, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Descriptive Efficacy of BRII-296 in Adults With Severe Postpartum Depression (PPD)
Recruitment & locations
CompletedSherman Oaks · Torrance · Boynton Beach
7 more locations
- Davie
- Miami Springs
- Atlanta
- Decatur
- Denver
- Fort Worth
- League City
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of BRII-296 for people with depression.
Who is behind this study?
The study sponsor is Brii Biosciences Limited.
Did this study involve medication?
Yes. The study involved medication, including BRII-296 and Depo Medrol.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit me